Please visit our previous years here:
Welcome to the 4th Annual Conference on Soft Mist Inhalers (SMIs)
SMI.London 2026
will take place on
Wednesday 10 June 2026
at the
Royal College of General Practitioners
30 Euston Square
London
This year we will focus on innovations from academia and early phase research. As we prepare the programme for the day, we invite academic researchers engaged in SMI R&D to send in their ideas for oral and poster presentations during the event. We would be pleased to consider them and help the academic community contribute fully to the SMI field. Send us an email with your ideas at info@smi.london to ask for an invitation.
Soft mist inhalers now represent nearly half of the portable inhaler market, reflecting their growing importance in both clinical and sustainability contexts. Recognized for their exceptional aerosol performance, deep-lung deposition, and reduced carbon footprint, SMIs are redefining standards in inhaled drug delivery. Their adaptability, user-friendly design, and strong compatibility with biologic therapies make them a vital platform for the next generation of respiratory and systemic treatments.
SMI are the essential “green inhaler”, ahead of pMDIs, nebulisers. They are also the tool for early phase clinical studies and ensure the smoothest transition to finished dosage form and market launch.